Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Harriet S Walter

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
The Lancet. Haematology|March 3, 2022
Chronic lymphocytic leukaemia therapy: is less more?Harriet S Walter, Martin J S Dyer
Blood|May 2, 2024
BCL2 inhibition: back to the future!Martin J S Dyer, Harriet S Walter
British Journal of Haematology|April 28, 2017
Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatmentMeike Vogler, Harriet S Walter, Martin J S Dyer
The New England Journal of Medicine|June 2, 2016
New Agents to Treat Chronic Lymphocytic LeukemiaHarriet S Walter, Gilles A Salles, Martin J S Dyer
British Journal of Cancer|September 10, 2025
A call for action: closing the gap on ethnic disparities in oral cavity cancer careNikila Patil, Zainab Lal, Thiagarajan Sridhar, et al.
Cancers|April 26, 2018
Responses to the Selective Bruton's Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell LinesRyohei Kozaki, Meike Vogler, Harriet S Walter, et al.
British Journal of Haematology|March 3, 2025
In vitro comparison of CD20xCD3 bispecific antibodies against diffuse large B-cell lymphoma (DLBCL) cell lines with different levels of expression of CD20Joshua S Bray, Gethin R Thomas, Victoria M Smith, et al.
Hemasphere|August 8, 2022
Successful Retreatment With Venetoclax in a Patient With Chronic Lymphocytic LeukemiaRoss A Jackson, Victoria M Smith, Sandrine Jayne, et al.
JCO Precision Oncology|February 1, 2022
Successful Treatment of Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type With Single-Agent VenetoclaxHarriet S Walter, Christopher S Trethewey, Matthew J Ahearne, et al.
British Journal of Nursing (Mark Allen Publishing)|June 1, 2022
Inequalities in cancer screening, prevention and service engagement between UK ethnic minority groupsShalin Abraham, Nalini Foreman, Zahirah Sidat, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
The Lancet. Haematology|March 3, 2022
Chronic lymphocytic leukaemia therapy: is less more?Harriet S Walter, Martin J S Dyer
Blood|May 2, 2024
BCL2 inhibition: back to the future!Martin J S Dyer, Harriet S Walter
British Journal of Haematology|April 28, 2017
Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatmentMeike Vogler, Harriet S Walter, Martin J S Dyer
The New England Journal of Medicine|June 2, 2016
New Agents to Treat Chronic Lymphocytic LeukemiaHarriet S Walter, Gilles A Salles, Martin J S Dyer
British Journal of Cancer|September 10, 2025
A call for action: closing the gap on ethnic disparities in oral cavity cancer careNikila Patil, Zainab Lal, Thiagarajan Sridhar, et al.
Cancers|April 26, 2018
Responses to the Selective Bruton's Tyrosine Kinase (BTK) Inhibitor Tirabrutinib (ONO/GS-4059) in Diffuse Large B-cell Lymphoma Cell LinesRyohei Kozaki, Meike Vogler, Harriet S Walter, et al.
British Journal of Haematology|March 3, 2025
In vitro comparison of CD20xCD3 bispecific antibodies against diffuse large B-cell lymphoma (DLBCL) cell lines with different levels of expression of CD20Joshua S Bray, Gethin R Thomas, Victoria M Smith, et al.
Hemasphere|August 8, 2022
Successful Retreatment With Venetoclax in a Patient With Chronic Lymphocytic LeukemiaRoss A Jackson, Victoria M Smith, Sandrine Jayne, et al.
JCO Precision Oncology|February 1, 2022
Successful Treatment of Primary Cutaneous Diffuse Large B-Cell Lymphoma Leg Type With Single-Agent VenetoclaxHarriet S Walter, Christopher S Trethewey, Matthew J Ahearne, et al.
British Journal of Nursing (Mark Allen Publishing)|June 1, 2022
Inequalities in cancer screening, prevention and service engagement between UK ethnic minority groupsShalin Abraham, Nalini Foreman, Zahirah Sidat, et al.
Pageof 3